Exact Mass: 546.393356

Exact Mass Matches: 546.393356

Found 83 metabolites which its exact mass value is equals to given mass value 546.393356, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

endo-1,4-beta-Xylanase

benzyl({3-[(4-{[3-(benzyldiethylazaniumyl)propyl]amino}-3,6-dioxocyclohexa-1,4-dien-1-yl)amino]propyl})diethylazanium

C34H50N4O2 (546.393356)


endo-1,4-beta-Xylanase is used in baked goods and brewing to treat whole grain, grain mashes and doughs to reduce viscosity for processing. Hydrolyses 1,4-b-D-xylosidic linkages in xylans. It is used in baked goods and brewing to treat whole grain, grain mashes and doughs to reduce viscosity for processing. Hydrolyses 1,4-b-D-xylosidic linkages in xylans

   

1-O,4-O-Bis[(2S)-2-ethylhexyl] 2-O-[(2R)-2-ethylhexyl] benzene-1,2,4-tricarboxylate

1-O,4-O-Bis[(2S)-2-ethylhexyl] 2-O-[(2R)-2-ethylhexyl] benzene-1,2,4-tricarboxylic acid

C33H54O6 (546.3920184)


   

3,5,6-Tris(2-ethylhexyl)benzene-1,2,4-tricarboxylic acid

3,5,6-Tris(2-ethylhexyl)benzene-1,2,4-tricarboxylic acid

C33H54O6 (546.3920184)


   

Trioctyl trimellitate

1,2,4-Trioctyl benzene-1,2,4-tricarboxylic acid

C33H54O6 (546.3920184)


   

DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.3920184)


DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.3920184)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.3920184)


DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C33H54O6 (546.3920184)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.3920184)


DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.3920184)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.3920184)


DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C33H54O6 (546.3920184)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.3920184)


DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.3920184)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.3920184)


DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C33H54O6 (546.3920184)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.3920184)


DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.3920184)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.3920184)


DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C33H54O6 (546.3920184)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.3920184)


DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.3920184)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.3920184)


DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C33H54O6 (546.3920184)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.3920184)


DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.3920184)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.3920184)


DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C33H54O6 (546.3920184)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   
   

(3R)-7,8,3,4,7,8-Hexadehydro-beta,beta-caroten-3-ol

(3R)-7,8,3,4,7,8-Hexadehydro-beta,beta-caroten-3-ol

C40H50O (546.3861449999999)


   

Allopurpurin

(3R)-7,8-Didehydro-beta,chi-caroten-3-ol

C40H50O (546.3861449999999)


   

Isotedaniazanthin

7,8-Didehydro-beta,phi-caroten-3-ol

C40H50O (546.3861449999999)


   

25-O-methyl-FD-892

25-O-methyl-FD-892

C33H54O6 (546.3920184)


   

methyl (23E)-(20S)-20,25-dihydroxy-26-acetoxy-3,4-secodammara-4(28),23-dien-3-oate

methyl (23E)-(20S)-20,25-dihydroxy-26-acetoxy-3,4-secodammara-4(28),23-dien-3-oate

C33H54O6 (546.3920184)


   
   

(24S)-5-hydroxy-24-methyl-5alpha-cholesta-7,22-dien-3beta-yl-D-xylopyranoside

(24S)-5-hydroxy-24-methyl-5alpha-cholesta-7,22-dien-3beta-yl-D-xylopyranoside

C33H54O6 (546.3920184)


   
   
   

methyl (23E)-(12R,20S)-12-acetoxy-20,25-dihydroxy-3,4-secodammara-4(28),23-dien-3-oate

methyl (23E)-(12R,20S)-12-acetoxy-20,25-dihydroxy-3,4-secodammara-4(28),23-dien-3-oate

C33H54O6 (546.3920184)


   
   

12-deacetoxypapyriferic acid|3-O-malonylepiocotillol II|3-O-malonylepiocotillol-II|3alpha-(carboxyacetoxy)-20(S),24(R)-epoxydammarane-25-ol

12-deacetoxypapyriferic acid|3-O-malonylepiocotillol II|3-O-malonylepiocotillol-II|3alpha-(carboxyacetoxy)-20(S),24(R)-epoxydammarane-25-ol

C33H54O6 (546.3920184)


   

ST 27:2;O;Hex

cholest-5,24-dien-3beta-yl beta-D-glucopyranoside

C33H54O6 (546.3920184)


   

Tetradehydrolycopenal

3,4,3,4-Tetradehydro-psi,psi-caroten-16-al

C40H50O (546.3861449999999)


   

Hexadehydro-beta-caroten-3-ol

(3R)-7,8,3,4,7,8-Hexahydro-beta,beta-carotene-3-ol

C40H50O (546.3861449999999)


   

Isotedaniaxanthin

7,8-Didehydrp-beta,phi-caroten-3-ol

C40H50O (546.3861449999999)


   

UNII:378539Q830

Tris(2-ethylhexyl) trimellitate

C33H54O6 (546.3920184)


   

trioctyl benzene-1,2,4-tricarboxylate

trioctyl benzene-1,2,4-tricarboxylate

C33H54O6 (546.3920184)


   

Xylanase

Benzoquinonium

C34H50N4O2+2 (546.393356)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist

   

DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(10:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C33H54O6 (546.3920184)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/10:0/0:0)

C33H54O6 (546.3920184)


   

DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(10:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C33H54O6 (546.3920184)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/10:0)

C33H54O6 (546.3920184)


   

DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(10:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C33H54O6 (546.3920184)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/10:0/0:0)

C33H54O6 (546.3920184)


   

DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(10:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C33H54O6 (546.3920184)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/10:0)

C33H54O6 (546.3920184)


   

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C33H54O6 (546.3920184)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/10:0/0:0)

C33H54O6 (546.3920184)


   

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C33H54O6 (546.3920184)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/10:0)

C33H54O6 (546.3920184)


   

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(10:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C33H54O6 (546.3920184)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/10:0/0:0)

C33H54O6 (546.3920184)


   

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(10:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C33H54O6 (546.3920184)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/10:0)

C33H54O6 (546.3920184)


   

DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(10:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C33H54O6 (546.3920184)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/10:0/0:0)

C33H54O6 (546.3920184)


   

DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(10:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C33H54O6 (546.3920184)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/10:0)

C33H54O6 (546.3920184)


   

DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(10:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C33H54O6 (546.3920184)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/10:0/0:0)

C33H54O6 (546.3920184)


   

DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(10:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C33H54O6 (546.3920184)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/10:0)

C33H54O6 (546.3920184)


   
   

2-[Carboxy-(3-octanoyloxy-2-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(3-octanoyloxy-2-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C29H56NO8+ (546.4005716)


   

2-[Carboxy-(2-decanoyloxy-3-nonanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(2-decanoyloxy-3-nonanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C29H56NO8+ (546.4005716)


   

TG(30:4)

TG(8:0_10:0_12:4)

C33H54O6 (546.3920184)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

AcHexZyE(0:0)

AcHexZyE(0:0)

C33H54O6 (546.3920184)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

3-({1-[5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid

3-({1-[5-(2-hydroxypropan-2-yl)oxolan-2-yl]-3a,3b,6,6,9a,11a-hexamethyl-dodecahydrocyclopenta[a]phenanthren-7-yl}oxy)-3-oxopropanoic acid

C33H54O6 (546.3920184)


   

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3as,5ar,7r,9ar,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C33H54O6 (546.3920184)


   

methyl 3-[(3s,3ar,5as,6s,7s,9ar,9br)-3-[(2s,4e,6r)-7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

methyl 3-[(3s,3ar,5as,6s,7s,9ar,9br)-3-[(2s,4e,6r)-7-(acetyloxy)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C33H54O6 (546.3920184)


   

methyl 3-[4-(acetyloxy)-3-(2,6-dihydroxy-6-methylhept-4-en-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

methyl 3-[4-(acetyloxy)-3-(2,6-dihydroxy-6-methylhept-4-en-2-yl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-6-yl]propanoate

C33H54O6 (546.3920184)